Houston, Texas, United States Related Funds
| Fund Name | Location |
| Altivia Ventures | Brazil, São Paulo, Sao Paulo |
| Chain Renaissance Capital | Beijing, Beijing, China |
| Elevate Capital | Oregon, Portland, United States |
| Focustar Capital | - |
| GROWWS | Czechia, Prague, Prague |
| Hongtu Kexin Chuangtou | China, Guangdong, Shenzhen |
| JMCR Partners | China, Hong Kong, Hong Kong Island |
| Knox Capital | Chicago, Illinois, United States |
| Newable | England, London, United Kingdom |
| Ningbo Yuerui Xinxi Keji Zhongxin | China, Ningbo Shi, Zhejiang |
| NTEC | Al Asimah, Al Kuwayt, Kuwait |
| Nuhma | - |
| Philadelphia Financial Group | Pennsylvania, Philadelphia, United States |
| Rock River Capital Partners | Madison, United States, Wisconsin |
| UCC Ueshima Coffee | Japan, Tokyo |
| Uqalo | - |
| Beijing, Beijing, China | |
| Wind River Financial | Madison, United States, Wisconsin |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Real Seq Biosciences | $1M | 28 Jul 2023 | Santa Cruz, California, United States | ||
Cari Health | $2M | 10 Jan 2023 | San Diego, California, United States | ||
Intrommune Therapeutics | $6M | 01 Jun 2021 | New York, New York, United States | ||
Zylö Therapeutics | $4M | 26 Sep 2019 | Greenville, South Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Real Seq Biosciences | $1M | 28 Jul 2023 | Santa Cruz, California, United States | ||
Cari Health | $2M | 10 Jan 2023 | San Diego, California, United States | ||
Intrommune Therapeutics | $6M | 01 Jun 2021 | New York, New York, United States | ||
Zylö Therapeutics | $4M | 26 Sep 2019 | Greenville, South Carolina, United States |
